发布求助
文献互助 智能选刊 最新文献

Advanced Nanobiomed Research最新文献

筛选
英文 中文
Advances in Nanocarriers for Delivering Therapeutic Agents Against Hepatitis B Virus 用于输送乙型肝炎病毒治疗药物的纳米载体的研究进展
IF 3.4
Advanced Nanobiomed Research Pub Date : 2024-03-25 DOI: 10.1002/anbr.202300132
Jia Li, Jianlan Yuan, Hugang Li, Jingyi Guo, Mingjun Li, Tingbin Zhang, Xing-Jie Liang, Haiming Fan, Xiaoli Liu
{"title":"Advances in Nanocarriers for Delivering Therapeutic Agents Against Hepatitis B Virus","authors":"Jia Li,&nbsp;Jianlan Yuan,&nbsp;Hugang Li,&nbsp;Jingyi Guo,&nbsp;Mingjun Li,&nbsp;Tingbin Zhang,&nbsp;Xing-Jie Liang,&nbsp;Haiming Fan,&nbsp;Xiaoli Liu","doi":"10.1002/anbr.202300132","DOIUrl":"10.1002/anbr.202300132","url":null,"abstract":"<p>Hepatitis B virus (HBV) infection is a crucial public health issue and a major cause of liver disease, such as cirrhosis and hepatocellular carcinoma. At present, orally administered small molecule drugs, such as nucleoside / nucleotide analogues, are recommended as the first-line treatment for HBV. However, the therapeutic efficacy of these drugs is hindered by off-target toxicity caused by the whole-body permeation distribution of these oral drugs. As an emerging drug delivery technology, systemically administered nanocarriers can enhance the aqueous solubility and stability of encapsulated drugs, prolong circulation times, and deliver them efficiently to the liver, showing great promise for increasing the safety and efficacy of small molecule drugs. Furthermore, nanocarriers also accelerate the clinical translation of new therapies, such as nucleic acids and vaccines. This review article highlights the progress of nanoparticle delivery systems in anti-HBV therapeutics and discusses the opportunities and challenges for the future development of anti-HBV nanotherapeutics.</p>","PeriodicalId":29975,"journal":{"name":"Advanced Nanobiomed Research","volume":"4 6","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202300132","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140382169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transdermal Delivery of Polymeric Nanoparticles Containing Aconite Root for the Treatment of Chemotherapy-Induced Peripheral Neuropathy 含乌头根的聚合物纳米粒子透皮给药用于治疗化疗引起的周围神经病变
IF 3.4
Advanced Nanobiomed Research Pub Date : 2024-03-25 DOI: 10.1002/anbr.202400006
Tae Eon Park, Man-Suk Hwang, Ki Su Kim
{"title":"Transdermal Delivery of Polymeric Nanoparticles Containing Aconite Root for the Treatment of Chemotherapy-Induced Peripheral Neuropathy","authors":"Tae Eon Park,&nbsp;Man-Suk Hwang,&nbsp;Ki Su Kim","doi":"10.1002/anbr.202400006","DOIUrl":"10.1002/anbr.202400006","url":null,"abstract":"<p>Chemotherapy-induced peripheral neuropathy (CIPN) poses challenges like pain and numbness, necessitating innovative treatments due to current limitations. Conventional approaches, relying on pain relief medications and dose adjustments, fall short in addressing neurotoxicity, resulting in inadequate pain relief and undesired effects. Aconite root (AR), a medicinal herb withcenturies of use against various diseases, contains a compound named Aconine, which alleviates pain by blocking specific neural channels. However, AR also contains Aconitine, a toxic substance hydrolyzed into nontoxic Aconine through heating. Herein, hyaluronate-poly(lactic<i>-co</i>-glycolic acid) nanoparticles (HA-PLGA/AR NPs) encapsulating Aconine are fabricated, enabling controlled release, protection, and transdermal delivery, enhancing therapeutic outcomes. High-performance liquid chromatography identifies optimal Aconine content after 48 h of AR boiling, with minimal neural toxicity confirmed. Characterization via transmission electron microscopy, dynamic light scattering, and in vitro assays demonstrates superior drug release by HA-PLGA/AR NPs, establishing effective transdermal Aconine delivery. In an in vitro CIPN model with paclitaxel (PTX)-treated PC12 cells, HA-PLGA/AR NPs stimulate enhanced neurite growth, validating their localized analgesic impact on CIPN and suggesting potential symptom alleviation. Taken together, HA-PLGA/AR NPs offer a promising strategy for controlled transdermal Aconine delivery, potentially alleviating CIPN and addressing various neuropathies and diseases.</p>","PeriodicalId":29975,"journal":{"name":"Advanced Nanobiomed Research","volume":"4 5","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202400006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140382872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hyperbaric Oxygen-Facilitated Cancer Treatment: A Minireview 高压氧辅助癌症治疗：微型访谈
IF 3.4
Advanced Nanobiomed Research Pub Date : 2024-03-10 DOI: 10.1002/anbr.202300162
Zi-Heng Li, Xinping Zhang, Fu-Gen Wu
{"title":"Hyperbaric Oxygen-Facilitated Cancer Treatment: A Minireview","authors":"Zi-Heng Li,&nbsp;Xinping Zhang,&nbsp;Fu-Gen Wu","doi":"10.1002/anbr.202300162","DOIUrl":"10.1002/anbr.202300162","url":null,"abstract":"<p>Hypoxia in malignant tumors is a major factor in inducing the failure of clinical cancer treatment. Although several strategies have been developed to relieve hypoxia, most are still in the preclinical research phase. Therefore, hyperbaric oxygen (HBO), an approved adjuvant therapy for alleviating hypoxia clinically, is an excellent choice for enhancing the efficacy of cancer treatment that is impeded by tumor hypoxia. In this minireview, recent advances in HBO-facilitated cancer treatment, including clinical applications and nanomedicine-mediated cancer therapy are introduced. At the end of this minireview, the potential challenges faced by HBO therapy before clinical use are discussed. It is hoped that this review will provide a reference for future clinical research on the application of HBO in cancer treatment.</p>","PeriodicalId":29975,"journal":{"name":"Advanced Nanobiomed Research","volume":"4 6","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202300162","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140255459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances in Pulmonary Protein Delivery Systems 肺蛋白输送系统的进展
IF 3.4
Advanced Nanobiomed Research Pub Date : 2024-03-08 DOI: 10.1002/anbr.202300176
Yuanyuan Zhao, Shuai Liu, Xueguang Lu
{"title":"Advances in Pulmonary Protein Delivery Systems","authors":"Yuanyuan Zhao,&nbsp;Shuai Liu,&nbsp;Xueguang Lu","doi":"10.1002/anbr.202300176","DOIUrl":"10.1002/anbr.202300176","url":null,"abstract":"<p>Protein-based therapeutics and vaccines play a pivotal role in the realm of biomedical science. Pulmonary administration offers several advantages including rapid adsorption, non-invasive, increased local drug concentration, and bypassed first-pass metabolism, thus holding great potential to address multiple unmet medical needs in lung-related diseases and vaccination. However, the limited success of inhaled proteins in clinical settings highlights the challenges associated with protein stability and the physiological barriers within the respiratory system. To overcome these hurdles, a variety of delivery systems including polymers, liposomes, cell-derived membranes, and inorganic materials are developed to improve the stability, mucus penetration, retention time, and bioavailability of proteins. With the outbreak of COVID-19, the pulmonary administration of proteins has drawn great attention. In this review, the design principle, preparation, biomedical application, progress in clinical translation, advantages, and disadvantages of each kind of delivery system are summarized, with an emphasis on carrier materials.</p>","PeriodicalId":29975,"journal":{"name":"Advanced Nanobiomed Research","volume":"4 5","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202300176","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140257252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Monitoring the Intracellular Fate of Molecular Beacons: The Challenge of False Positive Signals 监测分子信标的细胞内命运：假阳性信号的挑战
IF 3.4
Advanced Nanobiomed Research Pub Date : 2024-03-08 DOI: 10.1002/anbr.202300147
Diogo Volpati, Pedro H. B. Aoki, Therese B. Johansson, Roberto Munita, Frida Ekstrand, Sabrina Ruhrmann, Karl Bacos, Charlotte Ling, Christelle N. Prinz
{"title":"Monitoring the Intracellular Fate of Molecular Beacons: The Challenge of False Positive Signals","authors":"Diogo Volpati,&nbsp;Pedro H. B. Aoki,&nbsp;Therese B. Johansson,&nbsp;Roberto Munita,&nbsp;Frida Ekstrand,&nbsp;Sabrina Ruhrmann,&nbsp;Karl Bacos,&nbsp;Charlotte Ling,&nbsp;Christelle N. Prinz","doi":"10.1002/anbr.202300147","DOIUrl":"10.1002/anbr.202300147","url":null,"abstract":"<p>Molecular beacons (MBs) have been used on surfaces for detecting oligonucleotides. Attempts to use them intracellularly for monitoring mRNA content have been made, however, without any clear conclusion regarding the reliability of the method, mainly due to false positive signals. To reach an understanding of the intracellular fate of MBs, a critical question remains: how long after MB delivery and where in the cell does a false positive signal appear? To answer that question, the MB delivery method should allow for a time-stamped synchronized delivery of MBs to multiple cells, resulting in MBs being distributed in the cytosol immediately after delivery. Herein, nanostraws are used to inject MBs targeting insulin (<i>Ins1</i>) mRNA directly in the cytosol of clonal beta-cells, and the evolution of the MB fluorescence in time and space is monitored. The results show an MB translocation to the nucleus, where MBs are degraded or where they open nonspecifically, before the fluorophore alone is expelled back from the nucleus to the cytosol. The signal translocation to the nucleus and back to the cytosol is faster when scrambled MBs are used. The results shed light on the intracellular fate of MBs and highlight the short time scales before false positive signals become predominant.</p>","PeriodicalId":29975,"journal":{"name":"Advanced Nanobiomed Research","volume":"4 5","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202300147","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140257390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nanomedicine-Enabled Mild Photothermal Therapy Strategies for Enhanced Antitumor Treatment 增强抗肿瘤治疗的纳米药物温和光热疗法策略
IF 3.4
Advanced Nanobiomed Research Pub Date : 2024-03-07 DOI: 10.1002/anbr.202470031
Yongjuan Li, Xinran Zhu, Ya Dong, Yang Yang, Danyang Shen, Zhenzhen Li, Rui Li, Xiaowei Dang, Zhihai Qin, Kelong Fan
{"title":"Nanomedicine-Enabled Mild Photothermal Therapy Strategies for Enhanced Antitumor Treatment","authors":"Yongjuan Li,&nbsp;Xinran Zhu,&nbsp;Ya Dong,&nbsp;Yang Yang,&nbsp;Danyang Shen,&nbsp;Zhenzhen Li,&nbsp;Rui Li,&nbsp;Xiaowei Dang,&nbsp;Zhihai Qin,&nbsp;Kelong Fan","doi":"10.1002/anbr.202470031","DOIUrl":"https://doi.org/10.1002/anbr.202470031","url":null,"abstract":"<p><b>Photothermal Therapy</b>\u0000 </p><p>Mild photothermal therapy (mPTT, &lt;45 °C) has garnered considerable attention in antitumor therapy, despite the thermal resistance induced by heat shock proteins. In article 2300094, Kelong Fan and co-workers discuss the current landscape of photothermal agents, elucidate the underlying mechanisms of mPTT, highlight the benefits of mPTT in combination therapy, and explore the potential of nanomedicines to enhance mPTT efficacy.\u0000\u0000 <figure>\u0000 <div><picture>\u0000 <source></source></picture><p></p>\u0000 </div>\u0000 </figure></p>","PeriodicalId":29975,"journal":{"name":"Advanced Nanobiomed Research","volume":"4 3","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202470031","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140053113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances of Structural Design and Biomedical Applications of Tobacco Mosaic Virus Coat Protein 烟草花叶病毒外壳蛋白的结构设计和生物医学应用进展
IF 3.4
Advanced Nanobiomed Research Pub Date : 2024-03-07 DOI: 10.1002/anbr.202300135
Jialun Zhang, Haobo He, Fanmeng Zeng, Mingming Du, Dehua Huang, Guangcun Chen, Qiangbin Wang
{"title":"Advances of Structural Design and Biomedical Applications of Tobacco Mosaic Virus Coat Protein","authors":"Jialun Zhang,&nbsp;Haobo He,&nbsp;Fanmeng Zeng,&nbsp;Mingming Du,&nbsp;Dehua Huang,&nbsp;Guangcun Chen,&nbsp;Qiangbin Wang","doi":"10.1002/anbr.202300135","DOIUrl":"10.1002/anbr.202300135","url":null,"abstract":"<p>Recognized as the primary RNA virus to be categorized and extensively studied, the tobacco mosaic virus (TMV) is foundational to advancements in virology, molecular biology, and biomaterials. Over the past few decades, the deep comprehension of the TMV coat protein (TMVcp) molecular structure and assembly principles has stimulated a surge in research on TMVcp structural design using genetic engineering and chemical modification techniques. The unique characteristics of TMVcp, including its nanoscale orderly structure, ease of modification, and considerable drug loading capacity, have enabled significant progress in its biomedical applications. This review summarizes the advanced strategies deployed for TMVcp design and multidimensional assembly and underscores the prototypical applications of TMVcp-based biomaterials in bioimaging, drug delivery, tissue engineering, and biosensing. Ultimately, the future prospects of TMVcp research in structural design and biomedical applications are explored, which encompass artificial intelligence-guided structural and functional design, the development of stimulus-responsive biomaterials, and potential clinical translation.</p>","PeriodicalId":29975,"journal":{"name":"Advanced Nanobiomed Research","volume":"4 5","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202300135","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140260300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cutting-Edge Achievements of Inner Ear Drug Delivery Systems 内耳给药系统的尖端成果
IF 3.4
Advanced Nanobiomed Research Pub Date : 2024-03-01 DOI: 10.1002/anbr.202400004
Hui Zhang, Dongyu Xu, Huan Wang, Renjie Chai, Yuanjin Zhao
{"title":"Cutting-Edge Achievements of Inner Ear Drug Delivery Systems","authors":"Hui Zhang,&nbsp;Dongyu Xu,&nbsp;Huan Wang,&nbsp;Renjie Chai,&nbsp;Yuanjin Zhao","doi":"10.1002/anbr.202400004","DOIUrl":"10.1002/anbr.202400004","url":null,"abstract":"<p>The intricate physiological structure of the inner ear presents challenges for traditional medication treatment strategies, including systemic adverse responses, trouble penetrating the blood–labyrinth barrier, and low local cochlear concentration, resulting in poor therapeutic outcomes. An intriguing tactic that is extensively developed over decades is utilizing drug delivery systems to transport medication molecules to the inner ear. Herein, the challenges associated with inner ear delivery are discussed, cutting-edge achievements in inner ear drug delivery systems are emphasized, including nano-, micro-, and macrocarriers, and finally opportunities to leverage advanced technologies to improve existing drug delivery strategies are highlighted.</p>","PeriodicalId":29975,"journal":{"name":"Advanced Nanobiomed Research","volume":"4 6","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202400004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140087133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Natural Polymer-Based Materials for Wound Healing Applications 用于伤口愈合的天然聚合物基材料
IF 3.4
Advanced Nanobiomed Research Pub Date : 2024-02-22 DOI: 10.1002/anbr.202300131
Trinh Thi-Phuong Ho, Hien A. Tran, Vinh Khanh Doan, Joanneke Maitz, Zhe Li, Steven G. Wise, Khoon S. Lim, Jelena Rnjak-Kovacina
{"title":"Natural Polymer-Based Materials for Wound Healing Applications","authors":"Trinh Thi-Phuong Ho,&nbsp;Hien A. Tran,&nbsp;Vinh Khanh Doan,&nbsp;Joanneke Maitz,&nbsp;Zhe Li,&nbsp;Steven G. Wise,&nbsp;Khoon S. Lim,&nbsp;Jelena Rnjak-Kovacina","doi":"10.1002/anbr.202300131","DOIUrl":"10.1002/anbr.202300131","url":null,"abstract":"<p>Skin injuries pose significant health challenges, with conditions like burns and diabetic, venous, and pressure ulcers presenting complex wound management scenarios. Effective wound care strategies for these injuries encompass a range of interventions, from simple wound dressings to bioactive materials and surgical procedures involving skin substitutes and skin grafting. This review explores the potential of natural polymers, including silk, collagen, gelatin, elastin, cellulose, chitosan, alginate, and hyaluronic acid, in wound management. Natural polymers offer several advantages, including abundance, biodegradability, and compatibility with traditional and modern material fabrication techniques, and have demonstrated safety and efficacy in clinical applications, modulating various facets of the wound healing process. Highlighting preclinical and clinical studies, along with commercial products, this review showcases the versatility and utility of natural polymers in wound management and provides insights into emerging developments, such as 3D bioprinting and stimuli-responsive materials, which hold promise for personalized wound treatments. Additionally, we discuss the importance of the material format and morphology in engineering the next generation of wound dressings and skin substitutes, offering a pathway to optimize natural polymers for enhanced wound healing outcomes.</p>","PeriodicalId":29975,"journal":{"name":"Advanced Nanobiomed Research","volume":"4 5","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202300131","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140439724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advances and Challenges in Cerebral Organoids Research 脑有机体研究的进展与挑战
IF 3.4
Advanced Nanobiomed Research Pub Date : 2024-02-17 DOI: 10.1002/anbr.202300126
Dandan Luo, Jiaqi Xu, Fuyao Liu, Zhen Gu
{"title":"Advances and Challenges in Cerebral Organoids Research","authors":"Dandan Luo,&nbsp;Jiaqi Xu,&nbsp;Fuyao Liu,&nbsp;Zhen Gu","doi":"10.1002/anbr.202300126","DOIUrl":"https://doi.org/10.1002/anbr.202300126","url":null,"abstract":"<p>Cerebral organoids are three-dimensional (3D) aggregates with a more advanced composition, maturation, and architecture. It has emerged as a novel and sophisticated model system for studying neurodevelopment and neurological disorders, in comparison to conventional two-dimensional (2D) cell cultures. However, due to the extraordinarily complex nature of brain development, current cerebral organoids are not as functional and mature as brains. The development of cerebral organoids requires a culture system with sufficient developmental patterning factors, essential cell components, and vasculature. In this review, the critical factors and events that contribute to the development of cerebral organoids are focused on. The advanced design, fabrication techniques, and technologies are also discussed to enhance the application potential of cerebral organoid technology.</p>","PeriodicalId":29975,"journal":{"name":"Advanced Nanobiomed Research","volume":"4 5","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202300126","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141187437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信